These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence against hypercoagulability in coronary artery disease. Görög P; Ridler CD; Rees GM; Kovacs IB Thromb Res; 1995 Aug; 79(4):377-85. PubMed ID: 7482441 [TBL] [Abstract][Full Text] [Related]
4. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease. Kelleher CC Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657 [TBL] [Abstract][Full Text] [Related]
5. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370 [TBL] [Abstract][Full Text] [Related]
6. [Molecular biology, fibrinogen and thrombosis]. Ferrer-Antunes C; Palmeiro A Rev Port Cardiol; 1993 Jun; 12(6):577-81, 511. PubMed ID: 8333996 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet. Lowe GD J Thromb Haemost; 2005 Apr; 3(4):635-7. PubMed ID: 15842345 [No Abstract] [Full Text] [Related]
8. Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems. Kunz F; Pechlaner C; Erhart R; Zwierzina WD; Kemmler G Arterioscler Thromb; 1992 Dec; 12(12):1516-21. PubMed ID: 1450184 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. Meade TW J Thromb Haemost; 2005 Apr; 3(4):632-4. PubMed ID: 15842344 [No Abstract] [Full Text] [Related]
10. Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Halbmayer WM; Haushofer A; Radek J; Schön R; Deutsch M; Fischer M Coron Artery Dis; 1995 May; 6(5):397-402. PubMed ID: 7655727 [TBL] [Abstract][Full Text] [Related]
11. Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation. Lehmann KG; Gonzales E; Tri BD; Vaziri ND Am Heart J; 1999 Feb; 137(2):274-83. PubMed ID: 9924161 [TBL] [Abstract][Full Text] [Related]
12. [Hemostatic anomalies and coronary risk]. de Lorgeril M; Renaud S Rev Prat; 1992 Nov; 42(17):2136-40. PubMed ID: 1290035 [TBL] [Abstract][Full Text] [Related]
13. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963 [TBL] [Abstract][Full Text] [Related]
14. Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state. Patrassi GM; Toffanin F; Massa G; Schivazappa L; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):414-25. PubMed ID: 89993 [TBL] [Abstract][Full Text] [Related]
15. Independent association between lower level of social support and higher coagulation activity before and after acute psychosocial stress. Wirtz PH; Redwine LS; Ehlert U; von Känel R Psychosom Med; 2009 Jan; 71(1):30-7. PubMed ID: 19124624 [TBL] [Abstract][Full Text] [Related]
16. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Shechter M; Merz CN; Rude RK; Paul Labrador MJ; Meisel SR; Shah PK; Kaul S Am Heart J; 2000 Aug; 140(2):212-8. PubMed ID: 10925332 [TBL] [Abstract][Full Text] [Related]